Beta-blockers show no mortality benefit in MI patients with preserved ejection fraction
Beta-blockers do not lower death risk for heart attack patients with strong heart pumps
This meta-analysis of 23,524 adults with myocardial infarction and left ventricular ejection fraction ≥ 40% found that beta-blockers did not…
A large review found beta-blockers did not reduce death or heart failure in adults with heart attacks and normal heart function.
24-hour diastolic BP variability linked to renal decline in diabetic kidney disease
Why Your Blood Pressure Swings Matter More Than Numbers
This retrospective cohort study of 2143 patients with diabetic kidney disease found that each 1 mmHg increase in 24-hour diastolic blood pre…
Stability matters more than the number itself when protecting kidneys.
Beta-blockers show no benefit in preserved LVEF post-MI, but may help mildly reduced LVEF
Beta-blockers may not lower heart attack risk in patients with normal heart function.
This review of three randomized controlled trials and two meta-analyses found that beta-blocker therapy did not reduce death, MI, or heart f…
A review of trials suggests beta-blockers do not reduce death or heart failure in patients with preserved heart function, but may help those…
Meta-analysis finds beta-blockers may reduce cardiotoxicity risk during cancer therapy
Heart-Protecting Meds Show Promise for Cancer Patients
A meta-analysis of 19 RCTs in patients receiving anthracyclines and/or trastuzumab found beta-blockers improved LVEF (WMD=2.19) and reduced …
Two specific heart medications stand out as the most effective shields against heart damage caused by powerful cancer treatments.
Remote monitoring chatbot increased GDMT target dose achievement in recently discharged HFrEF patients compared to standard care.
A Simple Chatbot After Heart Failure Hospitalization May Keep You Healthier and Out of the Hospital
This randomized controlled trial enrolled 66 patients with heart failure with reduced ejection fraction (HFrEF) recently discharged from the…
For people with heart failure, consistent digital check-ins after leaving the hospital could be the key to getting the right medication stre…
Beta-blocker discontinuation noninferior to continuation in stable post-MI patients without heart failure
Stable heart attack patients may safely stop beta-blockers after one year, study finds
A randomized, open-label, noninferiority trial in 2540 stable post-MI patients with LVEF ≥40% and no heart failure who had received beta-blo…
Stable heart attack patients who stop beta-blockers after a year face similar risks to those who keep taking them, according to a major stud…